Superworth

Astrana Health price to free cash flow ASTH

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026
22.1×
9-year median
31.4×
Against its 9-year history
36th
percentile: 0 is its lowest day, 100 its highest
9-year range
2.7× to 254×
Peer median
12.1×

Astrana Health's price to free cash flow is 22.1× as of Oct 23, 2026.

That is below its 9-year median of 31.4×, close to the middle of its last 9 years.

Over that time it ranged from 2.7× in Nov 2017 to 254× in Dec 2019.

The median for 9 consulting Services stocks of a similar size is 12.1×.

Price to free cash flow over time

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far22.1×10.9×24.1×
202514.8×11.8×42.2×
202426.3×18.4×68.8×
202320.0×15.8×39.9×
202251.8×38.9×67.7×
202164.9×22.5×100×
202019.2×18.4×252×
2019250×13.4×254×
201815.3×5.1×16.1×
20178.2×2.7×8.2×
201619.4×18.4×19.4×
201515.9×15.9×464×
2014n/m a value too high to mean anything
201379.4×79.4×257×
2012322×322×322×

Against its peers

Companies in Consulting Services nearest Astrana Health's size, closest first, today.

CompanyPrice to free cash flow
ASTHAstrana Health22.1×
ICFIICF International8.5×
HURNHuron Consulting19.3×
EXPOExponent33.9×
FCNFTI Consulting12.1×
BWMNBowman Consulting59.1×
GGenpact LTD12.0×
BAHBooz Allen Hamilton8.4×
HCKTHackett9.8×
IIIInformation Services17.6×
Peer median12.1×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Astrana Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.